In addition, Kruglikov and Scherer proved through experiments that overexpression of CAV1 can cause a reduction in psoriasis inflammation and inhibit epidermal hyperplasia, which can be used as a pathological factor and a therapeutic target for psoriasis [29]. Here, CAV1 is linked to psoriasis.